Reversible Myocardial Injury Associated With SARS-CoV-2 in an Infant

Madhu Sharma; Samuel Gorstein; Margaret L Aldrich; Daphne T Hsu; Nadine F Choueiter

doi:10.1016/j.jaccas.2020.09.031

Reversible Myocardial Injury Associated With SARS-CoV-2 in an Infant

JACC Case Rep. 2020 Dec;2(15):2348-2352. doi: 10.1016/j.jaccas.2020.09.031. Epub 2020 Oct 12.

Authors

Madhu Sharma¹, Samuel Gorstein², Margaret L Aldrich³, Daphne T Hsu¹, Nadine F Choueiter¹

Affiliations

¹ Division of Pediatric Cardiology, Department of Pediatrics, Albert Einstein College of Medicine, Children's Hospital at Montefiore, Bronx, New York, USA.
² Division of Pediatric Critical Care Medicine, Department of Pediatrics, Albert Einstein College of Medicine, Children's Hospital at Montefiore, Bronx, New York, USA.
³ Division of Pediatric Infectious Disease, Department of Pediatrics, Albert Einstein College of Medicine, Children's Hospital at Montefiore, Bronx, New York, USA.

Abstract

Coronavirus disease-2019 is caused by the severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) and has been associated with myocardial dysfunction and heart failure in adult patients. We report a case of reversible myocardial injury and heart failure in an infant with SARS-CoV-2 infection. (Level of Difficulty: Intermediate.).

Keywords: COVID-19, coronavirus disease-2019; CRP, C-reactive protein; DOI, day of illness; ECG, electrocardiogram; LVEF, left ventricular ejection fraction; MR, mitral regurgitation; NT-proBNP, N-terminal pro-B natriuretic peptide; SARS-CoV-2, severe acute respiratory syndrome-coronavirus-2; TnT, Troponin T; coronavirus disease-2019; pediatrics; reversible myocardial injury.

Publication types

Case Reports